Search form

Sections

AstraZeneca

The Markingson Files: Heads start to roll as clinical trial suicide revelations mount

The University of Minnesota is replacing the chairman of its psychiatry department following two scathing reviews of its safety protocols in research involving human subjects and its recruitment of a troubled man who later died by suicide in a schizophrenia drug trial.

The Markingson Files: University of Minnesota under new scrutiny in drug trial death

Dan Markingson suffered from schizophrenia and killed himself in May 2004 while taking part in a clinical trial for an antipsychotic drug made by AstraZeneca. The evolving case continues to highlight problems of research oversight at the university and state levels.

The American Heart Association--Protecting Industry Not Patients by Barbara Roberts, MD, and Martha Rosenberg

The American Heart Association (AHA) and the American College of Cardiology (ACC) recently released new cardiovascular disease prevention guidelines. They are an egregious example of much that is wrong with medicine today.

Will Risperdal Settlement Change Anything?

Many say the only justice that will get Big Pharma's attention is frog marching the CEOs off to prison and/or cutting them off from their lucrative public trough of Medicare, Medicaid and military health programs.

Doctors report big pharma payouts for drug endorsements

The makers of popular drugs like Advair, Cymbalta, Viagra and Zoloft have physicians, psychiatrists, and medical school faculty members across California on their payrolls. Does this influence prescribing patterns?

Top Prescribers: How One Doctor Made Medi-Cal's Psychiatric Drug List

How does a doctor become a top prescriber of a psychiatric drug in one state’s Medicaid program? A "stunned" California psychiatrist tries to figure out why.

It's Complicated: Taking Conflict of Interest Beyond Pharma Payments to Researchers

I wrote a piece recently for Health News Review about conflicts of interest. The original post is below, followed by more great examples of writers describing unexpected conflicts in detail.

The Markingson Files: Court leaves key questions in clinical trial suicide unanswered

Any investigative reporter will tell you that a case dismissal does not necessarily mean a victory. Here's how that rule of thumb figures into the case of Dan Markingson, who committed suicide after participating in a clinical trial for the psychiatric drug Seroquel.

The Markingson Files: Conflicts of interest in clinical trials should be transparent

It can be uncomfortable asking people about their finances. In journalism, though, there is an obligation not only to ask, but to ask for proof — especially with clinical trials.

Pages

Announcements

Thanks to groundbreaking new research, we can now see how much private insurance plans are paying for common procedures and per person in communities across the U.S. This webinar will help journalists and policy makers contextualize the private-payer data, discuss possible policy responses, and offer suggestions for how reporters can use this resource to bolster their reporting. Register here.

Interested in learning more about the health, education and social challenges children face as a result of poverty and adversity?  Apply now for the 2016 National Health Journalism Fellowship, which comes with $2,000-$10,000 reporting grant, five days of intensive all-expenses-paid traing in L.A., and six months of mentoring. Details here.

CONNECT WITH THE COMMUNITY

Member Activities

Michelle Levander has shared a blog post

Read it.

Anna Romano has shared a blog post

Read it.

Elizabeth Vorrasi joined the community

Connect with Elizabeth Vorrasi

Doug Levy joined the community

Connect with Doug Levy

Mia Foreman's profile has been updated

Connect with Mia Foreman
More Member Activities

Follow Us

ReportingHealth